Profusa (PROFU) Forms Strategic Partnership With Mayo Clinic To Advance Oxygen Monitoring

Mayo Clinic and Profusa (PROFU) announced a strategic collaboration to integrate Profusa's high-impact, non-invasive oxygen monitoring technology into Mayo Clinic's clinical operations, effective February 15, 2026. The partnership aims to improve patient monitoring and outcomes in critical care and respiratory conditions by leveraging Profusa's patented sensor technology. The technology, designed for continuous, real-time monitoring, is expected to be implemented in Mayo Clinic's facilities in the first half of 2026, pending regulatory approvals. Profusa reported in its December 2025 earnings that the platform achieved a 40% reduction in hospital readmissions for patients with respiratory conditions, and the partnership is expected to expand this impact.